NCT03899922View on ClinicalTrials.gov

Monitoring Drug-induced Uveitis

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

April 1, 2020

Study Completion Date

April 4, 2023

Conditions
UveitisUveitis Drug-InducedEye DiseasesUvea--Diseases
Interventions
DRUG

Drugs inducing uveitis

Drugs susceptible to induce uveitis

Trial Locations (1)

75013

AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM, Paris

All Listed Sponsors
lead

Groupe Hospitalier Pitie-Salpetriere

OTHER

NCT03899922 - Monitoring Drug-induced Uveitis | Biotech Hunter | Biotech Hunter